Pantethine
Snapshot
| Indications | Contraindications |
|---|---|
Pantethine is the stable disulfide form of pantetheine, a vitamin B5 derivative and precursor of coenzyme A (CoA), the cofactor for fatty acid metabolism.1 It is taken chiefly to lower triglycerides and cholesterol, and to address fatty liver accompanying high triglycerides. It is also used in rare inherited disorders of CoA synthesis. Interest in alcohol metabolism and neuroprotection rests on hypothesis and review, not trials. The typical patient has mild to moderate dyslipidemia and low to moderate cardiovascular risk.
Placebo-controlled trials, from a 1984 double-blind study to a 2011 diet-controlled trial, found lower total and low-density lipoprotein (LDL) cholesterol, though the effect in lower-risk adults was small1, 3. A 2015 randomized trial in moderate dyslipidemia found pantethine lowered triglycerides, though CoA lowered them more2. A 2025 study of patients with an inherited CoA-synthesis cardiomyopathy and cell models found pantethine partially rescued cardiac cell function; no controlled trial has tested it. Products are mainly capsules, with softgels and tablets also sold; see Form comparison.
United States product labels warn that pantethine may interact with anticoagulant and antiplatelet medications, which is the main caution7. Per product labeling, a healthcare practitioner is consulted before use with such medications or before planned surgery7.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
26 sources, 16 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia.pubmed.ncbi.nlm.nih.govGaddi, Descovich, Noseda et al. · Atherosclerosis · 1984 · Pubmed
- 2Efficacy and tolerability of coenzyme A vs pantethine for the treatment of patients with hyperlipidemia: A randomized, double-blind, multicenter study.pubmed.ncbi.nlm.nih.govChen, Zhao, Zhao · Journal of clinical lipidology · 2015 · Pubmed
- 3Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk North American subjects: a triple-blinded placebo and diet-controlled investigation.pubmed.ncbi.nlm.nih.govRumberger, Napolitano, Azumano et al. · Nutrition research (New York, N.Y.) · 2011 · Pubmed
- 4The effects of pantethine on fatty liver and fat distribution.pubmed.ncbi.nlm.nih.govOsono, Hirose, Nakajima et al. · Journal of atherosclerosis and thrombosis · 2000 · Pubmed
- 5[Clinical study of the lipotropic activity of the preparation Fosfolip].pubmed.ncbi.nlm.nih.govLigas, Proietti, Chiti · Minerva medica · 1983 · Pubmed
- 6Pantethine ameliorates dilated cardiomyopathy features in PPCS deficiency disorder in patients and cell line models.pubmed.ncbi.nlm.nih.govZhang, Dorn, Gnutti et al. · Communications medicine · 2025 · Pubmed
- 7US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm